Phase I study of tamibarotene monotherapy in pediatric and young adult patients with recurrent/refractory solid tumors-Reference-Cited by-同舟云学术

Phase I study of tamibarotene monotherapy in pediatric and young adult patients with recurrent/refractory solid tumors

Published:2021-04-07 Issue:1 Volume:88 Page:99-107
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Nitani Chika^ORCID,Hara Junichi,Kawamoto Hiroshi,Taguchi Tomoaki,Kimura Toshimi,Yoshimura Kenichi,Hamada Akinobu,Kitano Shigehisa,Hattori Naoko,Ushijima Toshikazu,Ono Hiromi,Nakamoto Masako,Higuchi Tsukiko,Sato Akihiro

Funder

Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00280-021-04271-9.pdf

Reference26 articles.

1. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children’s Cancer Group. N Engl J Med 341:1165–1173. https://doi.org/10.1056/NEJM199910143411601

2. Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, Gerbing RB, London WB, Villablanca JG (2009) Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children’s oncology group study. J Clin Oncol 27:1007–1013. https://doi.org/10.1200/JCO.2007.13.8925

3. Maris JM (2010) Recent advances in neuroblastoma. N Engl J Med 362:2202–2211. https://doi.org/10.1056/NEJMra0804577

4. Hishiki T, Matsumoto K, Ohira M, Kamijo T, Shichino H, Kuroda T, Yoneda A, Soejima T, Nakazawa A, Takimoto T, Yokota I, Teramukai S, Takahashi H, Fukushima T, Kaneko T, Hara J, Kaneko M, Ikeda H, Tajiri T, Nakagawara A, Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG) (2018) Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG). Int J Clin Oncol 23:965–973. https://doi.org/10.1007/s10147-018-1281-8

5. Shiohira H, Kitaoka A, Shirasawa H, Enjoji M, Nakashima M (2010) Am 80 induces neuronal differentiation in a human neuroblastoma NH-12 cell line. Int J Mol Med 26:393–399

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Attempts to Improve Lipophilic Drugs’ Solubility and Bioavailability: A Focus on Fenretinide;Pharmaceutics;2024-04-24

2. Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects;Cancers;2024-01-26

3. Combination of a synthetic retinoid and a DNA demethylating agent induced differentiation of neuroblastoma through retinoic acid signal reprogramming;British Journal of Cancer;2021-10-11